SCHEMBL20985729

SCHEMBL20985729

COc1ccc(Cn2cc(-c3cc(C(F)F)nc(S(=O)(=O)CCCC(=O)NC45CC6CC(CC(C6)C4)C5)n3)ccc2=O)cc1OC

nearest known ligand 0.81

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SDHB P21912 11/20 0.81
▸ SMN1; SMN2 Q16637 6/20 0.41
▸ TP53 P04637 4/20 0.41
▸ POLB P06746 2/20 0.39
▸ HTT P42858 4/20 0.39
▸ STAT3 P40763 3/20 0.39
▸ STAT1 P42224 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ LMNA P02545 1/20 0.39
▸ PAX8 Q06710 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ MDM2 Q00987 1/20 0.38
▸ DHODH Q02127 1/20 0.37
▸ GAA P10253 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ RCE1 Q9Y256 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19806001 0.90 SDHB (1.00) SDHBSMN1; SMN2TP53POLBHTT
SCHEMBL21019832 0.90 SDHB (0.66) SDHBSMN1; SMN2TP53POLBHTT
SCHEMBL20985724 0.88 SDHB (0.63) SDHBSMN1; SMN2TP53POLBHTT
SCHEMBL21020171 0.84 SDHB (0.69) SDHBTP53
SCHEMBL21019873 0.84 SDHB (0.59) SDHBSMN1; SMN2TP53POLBHTT
SCHEMBL20985651 0.83 SDHB (0.64) SDHBSMN1; SMN2TP53POLBHTT
SCHEMBL20985693 0.83 SDHB (0.65) SDHBSMN1; SMN2TP53
SCHEMBL22912256 0.83 SDHB (0.87) SDHBSMN1; SMN2TP53POLBHTT
SCHEMBL20985674 0.83 SDHB (0.61) SDHBSMN1; SMN2TP53POLBHTT
SCHEMBL20985719 0.81 SDHB (0.62) SDHBSMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11725000-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2023-08-15 — — US disclosed
US-11725000-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2023-08-15 — — US disclosed
US-11725000-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2023-08-15 — — US disclosed
CN-110023292-B Apoptosis inhibitors 北京生命科学研究所 2022-10-04 — — CN disclosed
US-20210309647-A1 Apoptosis Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-10-07 — — US disclosed
US-20210309647-A1 Apoptosis Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-10-07 — — US disclosed
US-11034680-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-06-15 — — US disclosed
EP-3484854-B1 APOPTOSIS INHIBITORS NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING (CN) 2021-01-20 — — EP disclosed
US-20190152960-A1 Apoptosis Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2019-05-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190152960-A1 Apoptosis Inhibitors BAX, SDHA, SDHB SDHB 3/4885SMN1; SMN2 1698/4885TP53 160/4885
US-11725000-B2 Apoptosis inhibitors BAX, SDHA, SDHB SDHB 3/4885SMN1; SMN2 1698/4885TP53 160/4885
US-11034680-B2 Apoptosis inhibitors BAX, SDHA, SDHB SDHB 3/4885SMN1; SMN2 1698/4885TP53 160/4885
US-20210309647-A1 Apoptosis Inhibitors BAX, SDHA, SDHB SDHB 3/4885SMN1; SMN2 1698/4885TP53 160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback